http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6255049-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
filingDate 1998-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef1221a7cebd245aeb9998ee4509cc1d
publicationDate 2001-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6255049-B1
titleOfInvention Detection of metastatic cancer cells using PCTA-1
abstract This invention provides a method of detecting cancer metastatic cells in a subject, comprising: a) obtaining a nucleic acid sample from the subject's blood; b) amplifying nucleic acid encoding the product of prostate carcinoma tumor antigen gene-1; and c) detecting the presence of nucleic acid encoding the product of the prostate carcinoma tumor antigen gene-1, thereby detecting cancer metastatic cells in a subject. This invention also provides the above-described methods, wherein the method of amplification is PCR. This invention further provides the above-described methods, wherein the primers are 5'-AAGCTGACGCCTCATTTGCA-3' SEQ ID NO: 1 and 5'-AACCACCAATGGAACTGGGT-3' SEQ ID NO: 2. This invention also provides the above-described methods, wherein the primers are 5'-AATGGCTTCTGTGATACT-3' SEQ ID NO: 3 and 5'-GGCTATAAGTGTTGCTGC-3'SEQ ID NO: 4.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8414898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010173297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7968307-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003050266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03029421-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008069819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03029421-A2
priorityDate 1998-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9621671-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16759173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135986745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127376540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18402047

Total number of triples: 36.